Elisa Romeo

Elisa Romeo, PhD is currently serving as Chief Scientific and Regulatory Officer at RDI - Research & Development Institute and as a Board Member at SignPost Cancer Dx. With a background in biology, human physiology, and immunology, Elisa has held various leadership roles in operations and research & development at companies such as Bertis Bioscience, Silvergate Medical, and Drawbridge Health. Additionally, Elisa has provided independent consulting services at TE Biotech Consulting LLC and worked as a Chief Operations Officer at NephroSant, Inc. Throughout their career, Elisa has demonstrated expertise in the biotech industry and continues to make valuable contributions to the field.